InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
InMed Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: October 27, 2023
InMed Pharmaceuticals reported fiscal year 2022 executive compensation information on October 27, 2023.
In 2022, five executives at InMed Pharmaceuticals received on average a compensation package of $333K, a 35% decrease compared to previous year.
Average pay of disclosed executives at InMed Pharmaceuticals
Eric A. Adams, Chief Executive Officer, received $468K in total, which decreased by 36% compared to 2021. 78% of Adams' compensation, or $363K, was in salary. Adams also received $105K in option awards.
Michael Woudenberg, Chief Operating Officer, received a compensation package of $330K. 92% of the compensation package, or $302K, was in salary.
Bruce Colwill, Chief Financial Officer, earned $295K in 2022, a 43% decrease compared to previous year.
Alexandra Mancini, Senior Vice President, Clinical & Regulatory Affairs, received $290K in 2022, which decreases by 28% compared to 2021.
Eric Hsu, Senior Vice President, PreClinical R&D, earned $283K in 2022, a 29% decrease compared to previous year.
InMed Pharmaceuticals' fiscal year ends on June 30.
Related executives
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
Bruce Colwill
InMed Pharmaceuticals
Chief Financial Officer
You may also like
Source: SEC filing on October 27, 2023.